Home Search Abstracts Browse Sessions Program Committee Conference Webcasts Contact Us


Session 74   Poster Abstracts
Neuropathogenesis: Therapy and Clinical/Pre-Clinical Studies
Tuesday, 1:30 - 3:30 pm
Poster Hall
489HAART Modified Risk of HIV Dementia Associated to Increasing Age
P Lorenzini1, D Larussa1, A Cingolani2, I Uccella1, M Bongiovanni3, M L Giancola1, S Bossolasco4, F Moretti5, V Tozzi1, P Zannoni6, C F Perno1, A Ammassari2, A d'Arminio Monforte3, P Cinque4, A Antinori*1, and Italian Registry Investigative Neuro AIDS (IRINA)
1INMI Lazzaro Spallanzani, IRCCS, Rome, Italy; 2Catholic Univ. of S. Cuore, Rome, Italy; 3Univ. of Milan, Italy; 4Hosp. San Raffaele, Milan, Italy; 5Univ. degli Studi, Spedali Civili, Brescia, Italy; and 6Hosp. SS. Giacomo e Cristoforo, Massa, Italy
490
Novel High-concentration Capsaicin Patch for the Treatment of Painful HIV-aAssociated Distal Symmetrical Polyneuropathy: Results of an Open Label Trial
D Simpson*1, S Brown2, J Sampson3, L Estanislao1, C Vilahu4, S Ramanathan4, J Jermano4, and T von Stein4
1Mt. Sinai Med. Ctr., New York, NY; 2AIDS Res. Alliance, West Hollywood, CA, USA; 3The Res. & Education Group, Portland, OR; and 4NeurogesX, Inc., San Carlos, CA
491Efavirenz Suppress the Rate of Viral Replication in Human Brain Tissue Infected with Zidovudine-resistant HIV
A Kandanearatchi, A Vyakarnam, and I P Everall*
1Inst. of Psychiatry, Kings Coll., London, UK and Rayne Inst., Kings Coll., London, UK
492Lithium Improves HIV-associated Neurocognitive Impairment
S Letendre*, S Woods, R Ellis, J Atkinson, G van den Brande, J Durelle, I Grant, and The HNRC Group
Univ. of California, San Diego, USA
493NARC007: Clinical Validation of the AACTG NeuroScreen
R Ellis*1, K Robertson2, L Moo3, D Clifford4, Y Yang5, C Yiannoutsos6, and S Evans5
1Univ. of California, San Diego, USA; 2Univ. of North Carolina at Chapel Hill, USA; 3Johns Hopkins Univ., Baltimore, MD, USA; 4Washington Univ., St. Louis, MO, USA; 5Harvard Sch. of Publ. Hlth., Boston, MA, USA; and 6Indiana Univ. Sch. of Med., Indianapolis, USA
494
Broad-spectrum Micronutrient Supplementation in HIV-infected Patients with Dideoxynucleoside-related Peripheral Neuropathy: A Prospective, Double Blind, Placebo-controlled Trial
J Kaiser*1, J Ondercin2, G Santos3, G Leoung4, S Brown5, M Mass6, and M Baum7
1Univ. of California, San Francisco, USA; 2Jonathan Lax Treatment Ctr., Philadelphia, PA, USA; 3Betances Hlth. Ctr., New York, NY, USA; 4HIVCare, St. Francis Mem. Hosp., San Francisco, CA, USA; 5AIDS Res. Alliance, West Hollywood, CA, USA; 6California Pacific Med. Ctr., San Francisco, USA; and 7Florida Intl. Univ., Miami, USA
495
Potentially Preventive Effect of Didanosine against HIV Encephalopathy
I Poizot Martin*1, M P Milon2, M P Drogoul1, P Enel2, J A Gastaut1, and J Vion-Dury2,3
1CISIH, Hosp. Ste Marguerite, Marseille, France; 2Hosp. de la Conception, Marseille, France; and 3Hosp. de la Conception and Lab. de NeuroSci. Fonctionnelles, Marseille, France
496
The Effect of Smoked Marijuana on Chronic Neuropathic and Experimentally Induced Pain in HIV Neuropathy: Results of an Open-label Pilot Study
C Jay*, S Shade, H Vizoso, H Reda, K Petersen, M Rowbotham, and D Abrams
Univ. of California, San Francisco, USA
497Response of HIV-associated Sensory Neuropathies to Early Detection and Treatment Manipulation
C Cherry*1,2,3, J McArthur4, L Lal1, P Hauer4, and S Wesselingh1,2,3
1Macfarlane Burnet Inst. for Med. Res. and Publ. Hlth., Melbourne, Australia; 2Monash Univ., Melbourne, Australia; 3Alfred Hosp., Melbourne, Australia; and 4Johns Hopkins Univ., Baltimore, MD, USA
498
Improved Cognitive Function in Immune Reconstituted Advanced AIDS Patients Is Associated with Maintenance of HIV Suppression
A McCutchan*1, J Wu2, P Williams2, K Robertson3, R Ellis1, S Koletar4, and J Currier5
1Univ. of California, San Diego, USA; 2Harvard Sch. of Publ. Hlth., Boston, MA, USA; 3Univ. of North Carolina at Chapel Hill, USA; 4Ohio State Univ., Columbus, USA; and 5Univ. of California, Los Angeles, USA